Singapore: Minister of Jaisankar’s external affairs on Friday praised Quad – consisting of Australia, India, Japan and the US – efforts to produce, distribute Covid-19 vaccines and said that the group had a “strong and reliable supply chain”.
Speaking in the “Greater Power Competition: the world order that emerged” in Bloomberg’s new economic forum in Singapore, Jaishankar said, “Very interesting, one of the initiatives under Quad (Australia, India, Japan and the US) to jointly produce and distributing vaccines, which will become an American vaccine, made in India, Japan will come with a lot of financial support and Australians with a lot of logistical support.
“” For me, the globalization of decentralization, a more resiliable and reliable supply chain.
More trust and Transparency, but also a more flexible combination, sitting and producing solutions for certain challenges, “said Minister” if I not only see vaccines, if I see the pharmaceutical world, overall, there is time when hydroxychloroquine in high demand or paracetamol is also in demand.
Actually, we have germinated 10 times, even 15-20 times for different drugs, “Jaishank added AR.
.
He also shared Indian challenges during a pandemic and how strong the country rebounded.
“This is a test for us, a lot of it about our own survival, our own response.
I think we have come out of it very strong.
It is strong enough to be much more relevant for the health needs of the global public,” Minister said.
“The biggest lesson is that we should do a better job, build our own capacity.
Under Prime Minister Narendra Modi, has a program that is translated to build a relatively independent India,” Jaishankar said.
Talking about challenges, Jaishankar said that at the time of Indian pandemic only had two companies that assemble the ventilator and also did not have a mask producer.
“At that time when Covid-19 hit us, we have two companies that assemble the ventilator.
There is no N95 mask producer, we use it to get a valve from the outside and make it.
There is very little medical equipment.
During that period, we have been enhanced outside Usually.
Today, when I saw I saw health infrastructure that had grown in response to Covid-19.
We have actually established thousands of Covid-19 treatment centers that will last longer than Covid-19, “Jaishankar said.
He gave an example of transforming India in the health sector.
“We have a transformation in the health sector.
We have shown that with a combination of digital tools and creating a production facility that is possible for a country that has per capita income of less than $ 2000 to truly reach out in a great way in public health,” he added .
He also talked about India as the main vaccine production center and efficiency.
“The second takeaway for us is a positive takeaway, that is, why is India a major vaccine production center? Why do you have several vaccines, the same vaccine produced in various countries, but Indian plants have very high and efficient results? I think the quality of HR, the skills exist There.
Practice and tradition, many are really taken to bear the problem of Covid-19.
Has grown, “Jaishankar said.